SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (2812)11/15/1997 5:43:00 PM
From: Oliver & Co  Read Replies (1) of 6136
 
John, don't get all upset. Just do not pay attention. I do not know why he is posting all this rubbish, he will stop when we do not answer.
I just came back from the Agouron meeting. Believe me, this company is only going up. The RVPI is comming very soon, I would think the final paper is being drafted as we speak.
Thymitaq looks great, release for the end of 1998, excellent results when combined with radiation.
The MMP inhibitor they feel is the greatest thing since penicillin. Their phase 1 looks great.
European approval is expected by Jan-Feb.

So buy, buy, buy. And let Senor Henry say what he wants.

By the way, we all (HIV treaters) agree with you. Like Margaret Fischel said today,"we do not have the cure but we have treatments to tie us over till the cure".

Bye,

JLL
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext